GOLDMAN SACHS GROUP INC - ADC THERAPEUTICS SA ownership

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 41 filers reported holding ADC THERAPEUTICS SA in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ADC THERAPEUTICS SA
ValueSharesWeighting
Q3 2023$944,521
-61.4%
1,052,978
-7.4%
0.00%
Q2 2023$2,445,816
-46.7%
1,137,589
-51.7%
0.00%
-100.0%
Q1 2023$4,589,725
-44.7%
2,353,705
+8.9%
0.00%
-50.0%
Q4 2022$8,299,607
+5914.2%
2,161,356
+7442.7%
0.00%
Q3 2022$138,00028,6550.00%
Other shareholders
ADC THERAPEUTICS SA shareholders Q3 2023
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 1,680,149$24,681,0009.63%
Grosvenor Holdings, L.L.C. 1,517,212$22,288,0004.35%
Redmile Group, LLC 7,432,429$109,182,0003.41%
MPM BioImpact LLC 334,384$4,912,0001.32%
Indie Asset Partners, LLC 96,572$1,419,0001.07%
Eventide Asset Management 1,975,000$29,013,0000.46%
HHLR ADVISORS, LTD. 500,000$7,345,0000.15%
Virtus ETF Advisers LLC 19,193$282,0000.13%
Walleye Capital LLC 248,354$3,648,0000.10%
Matrix Capital Management Company, LP 400,000$5,876,0000.07%
View complete list of ADC THERAPEUTICS SA shareholders